| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 5625 |
| 1 | DOCETAXEL ANHYDROUS | 5625 |
| 2 | TRASTUZUMAB | 1370 |
| 3 | DOXORUBICIN HYDROCHLORIDE | 1075 |
| 4 | LISINOPRIL | 637 |
| 5 | ANASTROZOLE | 554 |
| 6 | CARBOPLATIN | 515 |
| 7 | METFORMIN | 467 |
| 8 | METFORMIN ER 500 MG | 455 |
| 9 | METFORMIN ER 750 MG | 455 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCETAXEL ANHYDROUS | 5625 | 0.0826 |
| 1 | DOCETAXEL | 5625 | 0.0826 |
| 2 | DOXORUBICIN HYDROCHLORIDE | 1075 | 0.0325 |
| 3 | PEGFILGRASTIM | 318 | 0.0265 |
| 4 | KETOCONAZOLE 1% | 3 | 0.0246 |
| 5 | TRASTUZUMAB | 1370 | 0.0197 |
| 6 | EPIRUBICIN HYDROCHLORIDE | 102 | 0.0157 |
| 7 | ANASTROZOLE | 554 | 0.0149 |
| 8 | ANASTROZOLE TABLETS | 280 | 0.0128 |
| 9 | ERGOCALCIFEROL | 373 | 0.0125 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 5637 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1383 |
| 2 | Aromatase Inhibitor [EPC] | 909 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 733 |
| 4 | Benzodiazepine [EPC] | 723 |
| 5 | Corticosteroid [EPC] | 573 |
| 6 | Platinum-based Drug [EPC] | 521 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 423 |
| 8 | Proton Pump Inhibitor [EPC] | 413 |
| 9 | Arteriolar Vasodilator [EPC] | 375 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 5637 | 0.0340 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1383 | 0.0185 |
| 2 | Provitamin D2 Compound [EPC] | 373 | 0.0125 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 94 | 0.0108 |
| 4 | Aromatase Inhibitor [EPC] | 909 | 0.0080 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 11 | 0.0053 |
| 6 | Potassium-sparing Diuretic [EPC] | 64 | 0.0048 |
| 7 | Arteriolar Vasodilator [EPC] | 375 | 0.0048 |
| 8 | Phenothiazine [EPC] | 100 | 0.0033 |
| 9 | Leukocyte Growth Factor [EPC] | 347 | 0.0024 |